Alpa Laboratories Profit & Loss Annual

BSE: 532878 | NSE: ALPA | ISIN: INE385I01010 | Sector: Biotechnology & Drugs

110.75 -2.55 (-2.25%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	108.74	92.96	112.27	97.55
Total Revenue	108.74	92.96	112.27	97.55
Costof Revenue Total	74.60	59.57	76.09	64.76
Gross Profit	34.13	33.39	36.18	32.80
Selling/ General/ Admin Expenses Total	13.29	16.15	11.93	11.75
Depreciation/ Amortization	1.95	1.33	1.66	1.23
Unusual Expense( Income)	0.00	-	-	0.00
Other Operating Expenses Total	12.74	5.86	13.58	13.36
Total Operating Expense	102.59	82.91	103.26	91.09
Operating Income	6.15	10.05	9.00	6.47
Interest Inc( Exp) Net- Non- Op Total	-3.59	31.03	-1.07	-0.26
Other Net	14.89	2.74	10.66	4.34
Net Income Before Taxes	20.68	15.89	19.56	10.79
Provisionfor Income Taxes	3.91	3.31	5.47	3.54
Net Income After Taxes	16.78	12.58	14.09	7.25
Net Income Before Extra Items	16.78	12.58	14.09	7.25
Net Income	16.78	12.58	14.09	7.25
Income Availableto Com Excl Extra Ord	16.78	12.58	14.09	7.25
Income Availableto Com Incl Extra Ord	16.78	12.58	14.09	7.25
Diluted Net Income	16.78	12.58	14.09	7.25
Diluted Weighted Average Shares	2.09	2.10	2.10	2.10
Diluted EPS Excluding Extra Ord Items	8.01	5.98	6.70	3.44
Diluted Normalized EPS	8.01	5.98	6.70	3.44
Total Adjustmentsto Net Income	-	-	0.00	-